Germany's Merck KGaA (MRK.XE) said Tuesday it has entered into a definitive agreement to acquire the microbiology business of Biotest AG (BIO.XE), Germany.

MAIN FACTS:

-A Merck spokesman Tuesday said the purchase price was up to EUR101 million before tax.

-The business has approximately 290 employees and generated sales of approximately EUR50 million in 2010.

-This business comprises heipha Dr. Muller GmbH, located in Eppelheim, Germany, as well as the Hycon business located in Dreieich, the subsidiaries in France, Japan and in the USA as well as further activities and employees in several European countries.

-The agreement is subject to antitrust approvals in Germany and Austria.

-Closing of the transaction is expected in the second half of 2011.

 
-Frankfurt Bureau, Dow Jones Newswires; 49-69-29725-500
Biotest (PK) (USOTC:BTTAY)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Biotest (PK) Charts.
Biotest (PK) (USOTC:BTTAY)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Biotest (PK) Charts.